FUROSEMIDE-AFT furosemide 20 mg/2 mL solution for injection ampoule

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

furosemide, Quantity: 10 mg/mL

Prieinama:

AFT Pharmaceuticals Pty Ltd

Vaisto forma:

Injection, solution

Sudėtis:

Excipient Ingredients: sodium hydroxide; nitrogen; sodium chloride

Vartojimo būdas:

Intramuscular, Intravenous, Intravenous Bolus, Intravenous Infusion

Vienetai pakuotėje:

10 ampoules

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Oedema: Furosemide ? AFT is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. It is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.,Furosemide ? AFT injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. If gastrointestinal absorption is impaired or oral medication is not practical for any reason, Furosemide ? AFT is indicated by the intravenous route. Parenteral use should be replaced with oral furosemide as soon as practical.

Produkto santrauka:

Visual Identification: Clear, colorless or lightly yellow solution; Container Type: Ampoule; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Registered

Leidimo data:

2022-05-09

Pakuotės lapelis

Furosemide – AFT
1
FUROSEMIDE – AFT
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I USING FUROSEMIDE – AFT?
Furosemide – AFT contains the active ingredient furosemide
(frusemide). Furosemide – AFT is a diuretic which helps reduce
the amount of excess fluid in the body by increasing the amount of
urine produced.
For more information, see Section 1. Why am I using Furosemide –
AFT? in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I USE FUROSEMIDE – AFT?
Do not use if you have ever had an allergic reaction to Furosemide –
AFT or any of the ingredients listed at the end of the CMI.
TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY
OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME
PREGNANT OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before I use
Furosemide – AFT? in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with Furosemide - AFT and affect how it
works.
A list of these medicines is in Section 3. What if I am taking other
medicines? in the full CMI.
4.
HOW DO I USE FUROSEMIDE – AFT?
Furosemide – AFT solution for injections are normally administered
to you by doctors or nurses in hospital
More instructions can be found in Section 4. How do I use Furosemide
– AFT? in the full CMI.
5.
WHAT SHOULD I KNOW WHILE USING FUROSEMIDE – AFT?
THINGS YOU
SHOULD DO
•
Remind any doctor, dentist or pharmacist you visit that you are using
Furosemide – AFT.
•
Make sure you drink enough water during any exercise and during hot
weather when you are using
Furosemide – AFT, especially if you sweat a lot
THINGS YOU
SHOULD BE
CAREFUL OF
•
If you feel light-headed, dizzy or faint, get up slowly when getting
out of bed or standing up.
•
If you are using Furosemide – AFT for a long period of time, you
should check with your doctor to
determine whether or not you should eat more p

Prekės savybės

AUSTRALIAN PRODUCT INFORMATION – FUROSEMIDE – AFT (FUROSEMIDE
(FRUSEMIDE)) SOLUTION FOR INJECTION
1
NAME OF THE MEDICINE
Furosemide (frusemide) sodium
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Furosemide (frusemide) 20 mg/ 2 mL solution for injection. Contains
160 µmol/mL of
sodium.
For the full list of excipients, see 6.1 List of excipients
3
PHARMCEUTICAL FORM
Furosemide – AFT solution for injection is a colourless or light
yellow, clear, sterile
aqueous solution contained in a 2 mL amber glass ampoule.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Oedema: Furosemide – AFT is indicated in adults, infants and
children for the treatment
of oedema associated with congestive heart failure, cirrhosis of the
liver and renal disease
including the nephrotic syndrome. It is particularly useful when an
agent with greater
diuretic potential than that of those commonly employed is desired.
Parenteral therapy
should
be
reserved
for
patients
unable
to
take
oral
medication
or
for
patients
in
emergency clinical situations.
Furosemide – AFT solution for injection is also indicated as
adjunctive therapy in acute
pulmonary oedema and cerebral oedema where intense and rapid onset of
diuresis is
desired. If gastrointestinal absorption is impaired or oral medication
is not practical for
any reason, Furosemide – AFT is indicated by the intravenous route.
Parenteral use
should be replaced with oral furosemide (frusemide) as soon as
practical.
4.2
DOSE AND METHOD OF ADMINISTRATION
ADULTS
Parenteral therapy with Furosemide – AFT should be used only in
patients unable to take
oral medication or in emergency situations and should be replaced with
oral therapy as
soon as practical. To achieve optimum efficacy and suppress
counter-regulation, a
continuous
furosemide
(frusemide)
infusion
is
generally
preferred
to
repeat
bolus
injections.
If a test dose of 40 to 80 mg furosemide (frusemide), injected slowly
IV over about 2 to 5
minutes, does not lead to increased diuresis within 30 minutes,
infusion treatment with
furosem